Form 4 for IRON Disc Medicine, Inc.
Accepted 2024-07-10 00:00:00 ET · period of report 2024-07-08 · accession 0000950170-24-082693 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-10 | 2024-07-08 | IRON | Quisel John D | CEO, Dir | M - OptEx | $1.01 | +3,000 | 72.1K | +4% | +$3,030 |
| D | 2024-07-10 | 2024-07-08 | IRON | Quisel John D | CEO, Dir | M - OptEx | $0.00 | -3,000 | 238.2K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-08 | M | A | 3,000 | $1.01 | 72,065 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-07-08 | M | D | 3,000 | $0.00 | 238,211 | D | $1.01 · — to 2030-03-10 | 3,000 Common Stock | (F1) The shares underlying this option are fully vested and exercisable as of the date hereof. |